leading glp-1 treatments for diabetes 2025 Is now the time to expand the benefits of medications people with type 1? These new study results indicate that it is…in a new study presented at #ADASciSessions, Dr. Viral GLP-1 Pipeline Update: November 2025

2021 Semaglutide enhances glucose-dependent insulin secretion and lowers HbA1c, studied extensively across the SUSTAIN clinical program for glycemic management

C.PerezD.RedaelliC.GloorB.TrentzO.et al (2001)

They act on receptors in the brain to reduce hunger and increase feelings of fullness, while also slowing gastric emptying

Chronic Knee Pain In one small study, 16 patients with ongoing knee pain got BPC157 injections in their knee joint

Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel

It imitates an intestinal hormone that stimulates insulin production, lowering your appetite and making you feel full